MAP2K7 and cancer: However, MAPK and PI3K signaling have been shown to protect some cancers against ERS‐induced cell death through various mechanisms.24, 25 We hypothesized that dual MEK‐PI3K inhibitor therapy in mucinous colon/appendix cancers would inhibit molecular pathways for survival and sensitize cells to ERS‐induced apoptosis.